Abstract:Long non-coding RNAs (lncRNAs), a class of RNA transcripts longer than 200 nucleotides, do not encode proteins; however, they encode small peptides and micropeptides that act as bioactive peptides with notable effects in regulating the progression of malignant tumors, such as lung and colorectal cancers, and affecting patient prognosis. lncRNAs are important intracellular regulators, particularly in tumorigenesis and tumor progression. Long intergenic non-protein coding RNA958 (LINC00958), which has received increasing attention in recent years, is highly expressed in various malignancies, including head and neck squamous cell carcinoma (HNSC), non-small-cell lung cancer (NSCLC), gastric cancer, hepatocellular carcinoma (HCC), colorectal cancer, bladder cancer, and breast cancer. Here, we reviewed the recent studies on LINC00958 as well as its closely related clinical features and functional regulation in cancers. We systematically expounded the molecular mechanisms underlying the biological functions of LINC00958 in inhibiting cell apoptosis and enhancing the chemoradiotherapy resistance of tumor cells. The upregulation of LINC00958 enhances the resistance of tumor cells to radiotherapy and chemotherapy and induces lymphangiogenesis. Moreover, it is involved in tumor glycolytic metabolism, which plays a crucial role in facilitating the proliferation, invasion, and migration of tumor cells. Additionally, analysis of various studies revealed that LINC00958 acts as an endogenous competitive RNA (ceRNA) and regulates the malignant behavior of tumor cells through the miRNA-mRNA axis. Collectively, the use of LINC00958 as a novel biomarker and therapeutic target for the clinical diagnosis and treatment of different cancers has bright prospects in the future.

A Review Of Linc00673 As A Novel Lncrna For Tumor Regulation

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

Dysregulation Of Long Non-Coding Rna In Breast Cancer: An Overview Of Mechanism And Clinical Implication

Linc00473: A Novel Oncogenic Long Noncoding Rna In Human Cancers

Review of LINC00707: A Novel LncRNA and Promising Biomarker for Human Diseases

New Insights into LINC00346 and its Role in Disease

The Emerging Roles of LINC00665 in Human Cancers

LINC01503 in cancer: from molecular mechanisms to therapeutic implications

Long Noncoding RNA LINC00467: Role in Various Human Cancers

Role of Long Non-Coding RNA LINC00641 in Cancer

LINC00467: an oncogenic long noncoding RNA

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

Roles, underlying mechanisms and clinical significances of LINC01503 in human cancers

Biological Functions and Molecular Mechanisms of LINC00961 in Human Cancer

Long Intergenic Non-Protein Coding RNA 173 in Human Cancers

LINC01089 in cancer: multifunctional roles and therapeutic implications

LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets

LINC00261: a Burgeoning Long Noncoding RNA Related to Cancer.

LINC00941: a novel player involved in the progression of human cancers

Upregulation of Long Intergenic Noncoding RNA 00673 Promotes Tumor Proliferation Via LSD1 Interaction and Repression of NCALD in Non-Small-cell Lung Cancer.

LINC00958: A promising long non-coding RNA related to cancer